Komal Kalani

713 total citations
26 papers, 560 citations indexed

About

Komal Kalani is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Komal Kalani has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Komal Kalani's work include Natural product bioactivities and synthesis (7 papers), Synthesis and biological activity (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Komal Kalani is often cited by papers focused on Natural product bioactivities and synthesis (7 papers), Synthesis and biological activity (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). Komal Kalani collaborates with scholars based in India, United States and China. Komal Kalani's co-authors include Santosh K. Srivastava, Feroz Khan, Shi Fang Yan, Shirley ShiDu Yan, Dharmendra Kumar Yadav, Anuradha Kalani, Sarfaraz Alam, Neetu Tyagi, Anirban Pal and Pradip K. Kamat and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Komal Kalani

25 papers receiving 552 citations

Peers

Komal Kalani

PHARM

CTM

Dev Bukhsh Singh India

Bader Alshehri Saudi Arabia

Abdulwahab Alamri Saudi Arabia

Langeswaran Kulanthaivel India

Maha M. Abdel‐Fattah Egypt

Sunhye Hong South Korea

S. M. Zahid Hosen Bangladesh

Alaa Sirwi Saudi Arabia

Chinmay Pal India

Sumanta Dey India

Dev Bukhsh Singh India

Komal Kalani

215 ×0.8

41 ×0.5

PHARM

54 ×0.6

124 ×1.5

CTM

78 ×1.4

Citations per year, relative to Komal Kalani Komal Kalani (= 1×) peers Dev Bukhsh Singh

Countries citing papers authored by Komal Kalani

Since Specialization

Citations

This map shows the geographic impact of Komal Kalani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Komal Kalani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Komal Kalani more than expected).

Fields of papers citing papers by Komal Kalani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Komal Kalani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Komal Kalani. The network helps show where Komal Kalani may publish in the future.

Co-authorship network of co-authors of Komal Kalani

This figure shows the co-authorship network connecting the top 25 collaborators of Komal Kalani. A scholar is included among the top collaborators of Komal Kalani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Komal Kalani. Komal Kalani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ashutosh, Ashutosh, et al.. (2025). Accelerated diabetic wound healing using a chitosan-based nanomembrane incorporating nanovesicles from Aloe barbadensis, Azadirachta indica, and Zingiber officinale. International Journal of Biological Macromolecules. 310(Pt 2). 143169–143169. 6 indexed citations

Kalani, Komal, et al.. (2023). Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics. Drug Discovery Today. 28(5). 103547–103547. 20 indexed citations

Chaturvedi, Pankaj, et al.. (2022). Exercise mitigates calpain induced Purkinje cell loss in diabetes. Life Sciences. 308. 120982–120982. 2 indexed citations

Kalani, Komal, et al.. (2021). Small Molecule Compounds Identified from Mixture-Based Library Inhibit Binding between Plasmodium falciparum Infected Erythrocytes and Endothelial Receptor ICAM-1. International Journal of Molecular Sciences. 22(11). 5659–5659. 8 indexed citations

Kalani, Komal. (2021). In-silico Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines. Current Topics in Medicinal Chemistry. 21(10). 908–919. 1 indexed citations

Kalani, Anuradha, et al.. (2019). A high methionine, low folate and vitamin B₆/B₁₂ containing diet can be associated with memory loss by epigenetic silencing of netrin-1. Neural Regeneration Research. 14(7). 1247–1247. 22 indexed citations

Kalani, Komal, Sarfaraz Alam, Vinita Chaturvedi, et al.. (2019). In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents. Current Topics in Medicinal Chemistry. 19(8). 633–644. 2 indexed citations

Kalani, Komal, Shi Fang Yan, & Shirley ShiDu Yan. (2018). Mitochondrial permeability transition pore: a potential drug target for neurodegeneration. Drug Discovery Today. 23(12). 1983–1989. 87 indexed citations

Sharma, Pooja, Aparna Shukla, Komal Kalani, et al.. (2016). Water Molecules Increases Binding Affinity of Natural PI3Kγ Inhibitors Against Cancer. Current Computer - Aided Drug Design. 11(4). 304–320. 2 indexed citations

10.

Kalani, Komal, Vinita Chaturvedi, Sarfaraz Alam, Feroz Khan, & Santosh K. Srivastava. (2015). Anti-Tubercular Agents from <i>Glycyrrhiza</i> glabra. Current Topics in Medicinal Chemistry. 15(11). 1043–1049. 16 indexed citations

11.

Kalani, Komal, et al.. (2015). QSAR-guided semi-synthesis and in vitro validation of antiplasmodial activity in ursolic acid derivatives. RSC Advances. 5(41). 32133–32143. 9 indexed citations

12.

Yadav, Dharmendra Kumar, Komal Kalani, Abhishek Kumar Singh, et al.. (2014). Design, Synthesis and In Vitro Evaluation of 18β-Glycyrrhetinic Acid Derivatives for Anticancer Activity Against Human Breast Cancer Cell Line MCF-7. Current Medicinal Chemistry. 21(9). 1160–1170. 39 indexed citations

13.

Kalani, Komal, Pooja Sharma, Richa Verma, et al.. (2014). In Vitro, In Silico and In Vivo Studies of Ursolic Acid as an Anti-Filarial Agent. PLoS ONE. 9(11). e111244–e111244. 18 indexed citations

14.

Shukla, Aparna, Pooja Sharma, Om Prakash, et al.. (2014). QSAR and Docking Studies on Capsazepine Derivatives for Immunomodulatory and Anti-Inflammatory Activity. PLoS ONE. 9(7). e100797–e100797. 35 indexed citations

15.

Kalani, Komal, et al.. (2014). QSAR Guided Semi-synthesis and In-Vitro Validation of Anticancer Activity in Ursolic Acid Derivatives. Current Topics in Medicinal Chemistry. 14(8). 1005–1013. 15 indexed citations

16.

Kalani, Anuradha, Pradip K. Kamat, Komal Kalani, & Neetu Tyagi. (2014). Epigenetic impact of curcumin on stroke prevention. Metabolic Brain Disease. 30(2). 427–435. 39 indexed citations

17.

Kalani, Komal, et al.. (2013). Glycyrrhetinic acid and its analogs: A new class of antifilarial agents. Bioorganic & Medicinal Chemistry Letters. 23(9). 2566–2570. 34 indexed citations

18.

Kalani, Komal, Jyoti Agarwal, Sarfaraz Alam, et al.. (2013). In Silico and In Vivo Anti-Malarial Studies of 18β Glycyrrhetinic Acid from Glycyrrhiza glabra. PLoS ONE. 8(9). e74761–e74761. 56 indexed citations

19.

Yadav, Dharmendra Kumar, Komal Kalani, Feroz Khan, & Santosh K. Srivastava. (2013). QSAR and Docking Based Semi-synthesis and in vitro Evaluation of 18 β-glycyrrhetinic Acid Derivatives Against Human Lung Cancer Cell Line A-549. Medicinal Chemistry. 9(8). 1073–1084. 34 indexed citations

20.

Kalani, Komal, et al.. (2012). Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activity. Journal of Molecular Modeling. 18(7). 3389–3413. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact